研究者
J-GLOBAL ID:201801017837392673
更新日: 2024年12月21日
枝廣 陽子
Edahiro Yoko
競争的資金等の研究課題 (1件):
- 2019 - 2022 iPS細胞を用いたインターフェロンの腫瘍幹細胞に対する抗腫瘍作用機序の解明
論文 (75件):
-
Chiho Furuya, Yoshinori Hashimoto, Soji Morishita, Yasutaka Fukuda, Tadaaki Inano, Tomonori Ochiai, Shuichi Shirane, Yoko Edahiro, Marito Araki, Miki Ando, et al. A higher JAK2V617F allele burden may be a risk factor for hemorrhagic events in younger patients with polycythemia vera. Hematology (Amsterdam, Netherlands). 2024. 29. 1. 2427905-2427905
-
Yoko Edahiro, Tomonori Ochiai, Yoshinori Hashimoto, Michiko Ichii, Takeshi Okatani, Hiromi Omura, Kei Nakajima, Makoto Sasaki, Jun Ando, Tomoiku Takaku, et al. Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan. Hematology (Amsterdam, Netherlands). 2024. 29. 1. 2340149-2340149
-
Keiki Nagaharu, Eiko Ohya, Yoko Edahiro, Yoshinori Hashimoto, Tomoki Ito, Akihiko Gotoh, Mika Nakamae, Fumihiko Kimura, Michiaki Koike, Keita Kirito, et al. Correction to: Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysis. Annals of hematology. 2024. 103. 10. 4349-4350
-
Keiki Nagaharu, Eiko Ohya, Yoko Edahiro, Yoshinori Hashimoto, Tomoki Ito, Akihiko Gotoh, Mika Nakamae, Fumihiko Kimura, Michiaki Koike, Keita Kirito, et al. Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysis. Annals of hematology. 2024. 103. 9. 3535-3541
-
Chiho Furuya, Soji Morishita, Yoshinori Hashimoto, Tadaaki Inano, Tomonori Ochiai, Shuichi Shirane, Yoko Edahiro, Marito Araki, Miki Ando, Norio Komatsu. Impact of non-driver gene mutations on thrombo-haemorrhagic events in ET patients. British journal of haematology. 2024. 204. 1. 221-228
もっと見る
MISC (47件):
-
Yoko Edahiro, Shuichi Shirane, Jun Takeda, Hajime Yasuda, Tadaaki Inano, Miyuki Tsutsui, Yasuharu Hamano, Makoto Sasaki, Jun Ando, Atsuo Itakura, et al. Assessment and management of pregnancy in patients with myeloproliferative neoplasms: insights from a single-institution study of 29 neonates. International Journal of Hematology. 2024
-
橋本 由徳, 枝廣 陽子, 伊藤 量基, 後藤 明彦, 中前 美佳, 木村 文彦, 小池 道明, 桐戸 敬太, 和田 秀穂, 臼杵 憲祐, et al. A nationwide survey on Japanese patients with essential thrombocythemia: JSH-MPN-R18 study(和訳中). 日本血液学会学術集会. 2021. 83回. OS3-3
-
森下総司, 安田肇, 山脇紗耶, 川路英哉, 伊藤昌可, 枝廣陽子, 今井美沙, 向後泰司, 常田聡, 大坂顯通, et al. 骨髄増殖性腫瘍の新規汎用診断マーカー. 日本血液学会学術集会抄録(Web). 2020. 82nd
-
枝廣 陽子, 小松 則夫. 骨髄線維症患者に対するruxolitinibの有効性と安全性 単施設での後方視的検討. 臨床血液. 2019. 60. 7. 755-760
-
荒木 真理人, 楊 印杰, 増渕 菜弥, 林 英里奈, 水上 喜久, 木原 慶彦, 今井 美沙, 弘中 由美, ぬで島 麻衣, 枝廣 陽子, et al. MPN関連 calreticulin変異による骨髄増殖性腫瘍発症の分子メカニズム. Cytometry Research. 2019. 29. Suppl. 40-40
もっと見る
前のページに戻る